Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
Public ClinicalTrials.gov record NCT02907593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Steroids and Surfactant in Extremely Low Gestation Age Infants Pilot Dose Escalation Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase I/II open-label study to determine the lowest, safe, effective dose of budesonide given with calfactant as the vehicle.
Study identification
- NCT ID
- NCT02907593
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Days to 14 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Mar 31, 2018
- Completion
- Mar 31, 2018
- Last update posted
- Apr 3, 2025
2016 – 2018
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | — |
| University of Florida, Jacksonville | Jacksonville | Florida | 32209 | — |
| Florida Hospital for Children | Orlando | Florida | 32803 | — |
| Oregon Health ans Science University | Portland | Oregon | 97239 | — |
| Vanderbilt Children's Hospital | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Bronchopulmonary Dysplasia (BPD) trials
Other public records listing Bronchopulmonary Dysplasia (BPD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07417111: Continued Pressure for Alveolar Protection (CPAP Trial) Recruiting
- NCT04545866: The Budesonide in Babies (BiB) Trial Active, not recruiting
- NCT07101640: PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia Recruiting
- NCT07447739: Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively? Not yet recruiting
- NCT07120971: Metformin for Premature Infants With Bronchopulmonary Dysplasia Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02907593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02907593 live on ClinicalTrials.gov.